Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
The cholecystokinin-A receptor mediates inhibition of food intake yet is not essential for the maintenance of body weight
Alan S. Kopin, … , Robin Kanarek, Martin Beinborn
Alan S. Kopin, … , Robin Kanarek, Martin Beinborn
Published February 1, 1999
Citation Information: J Clin Invest. 1999;103(3):383-391. https://doi.org/10.1172/JCI4901.
View: Text | PDF | Erratum
Article

The cholecystokinin-A receptor mediates inhibition of food intake yet is not essential for the maintenance of body weight

  • Text
  • PDF
Abstract

Food intake and body weight are determined by a complex interaction of regulatory pathways. To elucidate the contribution of the endogenous peptide cholecystokinin, mice lacking functional cholecystokinin-A receptors were generated by targeted gene disruption. To explore the role of the cholecystokinin-A receptor in mediating satiety, food intake of cholecystokinin-A receptor–/– mice was compared with the corresponding intakes of wild-type animals and mice lacking the other known cholecystokinin receptor subtype, cholecystokinin-B/gastrin. Intraperitoneal administration of cholecystokinin failed to decrease food intake in mice lacking cholecystokinin-A receptors. In contrast, cholecystokinin diminished food intake by up to 90% in wild-type and cholecystokinin-B/gastrin receptor–/– mice. Together, these findings indicate that cholecystokinin-induced inhibition of food intake is mediated by the cholecystokinin-A receptor. To explore the long-term consequences of either cholecystokinin-A or cholecystokinin-B/gastrin receptor absence, body weight as a function of age was compared between freely fed wild-type and mutant animals. Both cholecystokinin-A and cholecystokinin-B/gastrin receptor–/– mice maintained normal body weight well into adult life. In addition, each of the two receptor–/– strains had normal pancreatic morphology and were normoglycemic. Our results suggest that although cholecystokinin plays a role in the short-term inhibition of food intake, this pathway is not essential for the long-term maintenance of body weight.

Authors

Alan S. Kopin, Wendy Foulds Mathes, Edward W. McBride, Minh Nguyen, Wisam Al-Haider, Frank Schmitz, Susan Bonner-Weir, Robin Kanarek, Martin Beinborn

×

Figure 5

Options: View larger image (or click on image) Download as PowerPoint
CCK-AR–/– mice have normal pancreatic histology and blood glucose levels...
CCK-AR–/– mice have normal pancreatic histology and blood glucose levels (a) Normal histology of exocrine and endocrine pancreatic tissue from CCK-AR–/– mice. Non-β islet cells were immunostained; sections were counterstained with hematoxylin and eosin. Both the islet and acinar gland morphology are comparable in wild-type (WT) and CCK-AR–/– (knockout, or KO) mice (see text). The pancreatic histology that is shown is representative of sections from five age-matched pairs (WT and CCK-AR–/–) of male mice. (b) Blood glucose levels in CCK-AR–/– mice are not significantly different from the respective values of age- and sex-matched wild-type controls. Morning glucose levels were determined in freely fed mice. Average age and number of animals in the corresponding groups were as follows: 311 ± 53 days (12 wild-type males); 286 ± 57 days (10 CCK-AR–/– males); 307 ± 54 days (15 wild-type females); 330 ± 54 days (14 CCK-AR–/– females). Data are given as mean ± SD. Student's t values for glucose comparisons between wild-type and CCK-AR–/– mice were: t(20) = 0.27, P = 0.79 (males); t(27) = 1.46, P = 0.16 (females).

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts